Camphene
Active ingredient
- Drug class
- -
- Availability
- See label
- Markets covered
- 1
- Products on record
- 2
Overview
Camphene is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 2 | April 1, 2021 |
GBUnited Kingdom· MHRA
2 products
Uses
Urolithiasis, nephrolithiasis and mild urinary tract infections. ROWATINEX promotes the disintegration of stones, and by its spasmolytic action promotes the spontaneous passage of stones in the renal and urinary tracts. ROWATINEX gives symptomatic relief of mild to moderate renal and urinary colic associated with the presence of stones in the renal and urinary tracts.
ROWATINEX is also indicated for the relief of frequency and urgency associated with mild urinary tract infections.
How to take
Sources & citations
- [1]MHRA (UK) · PL000070003 · revised April 1, 2021
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.